Literature DB >> 10218761

Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders.

J W Heinecke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10218761     DOI： 10.1016/s0022-2143(99)90061-6

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  23 in total

1.  Local kappa opioid receptor activation decreases temporomandibular joint inflammation.

Authors:  Tânia C Chicre-Alcântara; Karla E Torres-Chávez; Luana Fischer; Juliana T Clemente-Napimoga; Vilma Melo; Carlos Amílcar Parada; Claudia Herrera Tambeli
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Myeloperoxidase in chronic kidney disease.

Authors:  A Madhusudhana Rao; Usha Anand; C V Anand
Journal:  Indian J Clin Biochem       Date:  2010-09-14

3.  Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.

Authors:  Kevin Li-ChunHsieh; Stefan Schob; Matthias W G Zeller; Benjamin Pulli; Muhammad Ali; Cuihua Wang; Terry Ting-Yu Chiou; Yuk-Ming Tsang; Po-Shun Lee; Thomas P Stossel; John W Chen
Journal:  J Neuroimmunol       Date:  2015-08-09       Impact factor: 3.478

4.  Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation.

Authors:  Martin D Rees; David I Pattison; Michael J Davies
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

5.  Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation.

Authors:  Ruizheng Shi; Changping Hu; Qiong Yuan; Tianlun Yang; Jun Peng; Yuanjian Li; Yongping Bai; Zehong Cao; Guangjie Cheng; Guogang Zhang
Journal:  Cardiovasc Res       Date:  2011-02-03       Impact factor: 10.787

6.  Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

Authors:  C Roger White; Geeta Datta; Paulina Mochon; Zhenghao Zhang; Ollie Kelly; Christine Curcio; Dale Parks; Mayakonda Palgunachari; Shaila Handattu; Himanshu Gupta; David W Garber; G M Anantharamaiah
Journal:  Vasc Dis Prev       Date:  2009-01-01

7.  Fragmentation of extracellular matrix by hypochlorous acid.

Authors:  Alan A Woods; Michael J Davies
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

8.  Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.

Authors:  John W Chen; Michael O Breckwoldt; Elena Aikawa; Gloria Chiang; Ralph Weissleder
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

9.  Increased plasma myeloperoxidase levels in systemic lupus erythematosus.

Authors:  Rosa Weiss Telles; Gilda Aparecida Ferreira; Neusa Pereira da Silva; Emilia Inoue Sato
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

10.  Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation.

Authors:  Yi Wang; Henry Rosen; David K Madtes; Baohai Shao; Thomas R Martin; Jay W Heinecke; Xiaoyun Fu
Journal:  J Biol Chem       Date:  2007-08-28       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.